Ultrasound-Mediated In Vivo Biodistribution of Coumarin-Labeled Sorafenib-Loaded Liposome-Based Nanotheranostic System

References

• Berkes C, Franco J, Lawson M et al. Kinase inhibitor library screening identifies the cancer therapeutic sorafenib and structurally similar compounds as strong inhibitors of the fungal pathogen Histoplasma capsulatum. Antibiotics 10(10), 1223 (2021).
   Google Scholar
• Iacobazzi RM, Vischio F, Arduino I et al. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles. J. Colloid. Interface Sci. 608, 239–254 (2022).
   PubMed Web of Science ®Google Scholar
• Ye H, Zhou L, Jin H, Chen Y, Cheng D, Jiang Y. Sorafenib-loaded long-circulating nanoliposomes for liver cancer therapy. BioMed. Res. Int. 2020, 1–12 (2020).
   Web of Science ®Google Scholar
• Younis MA, Khalil IA, Elewa YH, Kon Y, Harashima H. Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo. J. Control. Rel. 331, 335–349 (2021).
   PubMed Web of Science ®Google Scholar
• Park SY, Kang Z, Thapa P et al. Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach. Int. J. Pharm. 566, 229–238 (2019).
   PubMed Web of Science ®Google Scholar
• Park J-H, Baek M-J, Lee J-Y, Kim K-T, Cho H-J, Kim D-D. Preparation and characterization of sorafenib-loaded microprecipitated bulk powder for enhancing oral bioavailability. Int. J. Pharm. 589, 119836 (2020).
   PubMedGoogle Scholar
• Yang S, Zhang B, Gong X, Wang T, Liu Y, Zhang N. In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer. Int. J. Nanomed. 11, 2329 (2016).
   PubMed Web of Science ®Google Scholar
• Su Y, Wang K, Li Y et al. Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy. Nanomedicine 13(9), 1009–1023 (2018).
   PubMed Web of Science ®Google Scholar
• Fan G, Wei X, Xu X. Is the era of sorafenib over? A review of the literature. Ther. Adv. Med. Oncol. 12, 1758835920927602 (2020).
   Web of Science ®Google Scholar
• Gonzalez-Valdivieso J, Girotti A, Schneider J, Arias FJ. Advanced nanomedicine and cancer: challenges and opportunities in clinical translation. Int. J. Pharm. 599, 120438 (2021).
   PubMedGoogle Scholar
• Patel K, Bothiraja C, Mali A, Kamble R. Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small-cell lung cancer. Part. Sci. Technol. 39(8), 990–999 (2021).
   Web of Science ®Google Scholar
• Ruman U, Buskaran K, Pastorin G, Masarudin MJ, Fakurazi S, Hussein MZ. Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of sorafenib drug in hepatocellular carcinoma and colorectal adenocarcinoma cells. Nanomaterials 11(2), 497 (2021).
   Web of Science ®Google Scholar
• Zahednezhad F, Mojarrad JS, Zakeri-Milani P et al. Surface modification with cholesteryl acetyl carnitine, a novel cationic agent, elevates cancer cell uptake of the PEGylated liposomes. Int. J. Pharm. 609, 121148 (2021).
   PubMedGoogle Scholar
• Li J, Li Z, Gao Y et al. Effect of a drug delivery system made of quercetin formulated into PEGylation liposomes on cervical carcinoma in vitro and in vivo. J. Nanomater. 2021, 12 (2021).
   Web of Science ®Google Scholar
• Stylianopoulos T. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors. Ther. Deliv. 4(4), 421–423 (2013).
   PubMedGoogle Scholar
• Fan Y, Marioli M, Zhang K. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. J. Pharm. Biomed. Anal. 192, 113642 (2021).
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang T, Zhang M, Hu W. Detection of folic acid and imaging of folate receptor overexpressed cancer cells via a far-red silver nanoclusters with baseline resolved between excitation and emission. Dyes Pigments 198, 109984 (2022).
   Web of Science ®Google Scholar
• Luiz MT, Dutra JAP, de Cássia Ribeiro T et al. Folic acid-modified curcumin-loaded liposomes for breast cancer therapy. Colloid. Surf. Physicochem. Eng. Asp. 645, 128935 (2022).
   Web of Science ®Google Scholar
• Silva CO, Pinho JO, Lopes JM, Almeida AJ, Gaspar MM, Reis C. Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics 11(1), 22 (2019).
   PubMed Web of Science ®Google Scholar
• Choi J-S, Park J-W, Seu Y-B, Doh K-O. Enhanced efficacy of folate-incorporated cholesteryl doxorubicin liposome in folate receptor abundant cancer cell. J. Drug Deliv. Sci. Technol. 62, 102385 (2021).
   Web of Science ®Google Scholar
• Gao W. Preparation and evaluation of folate receptor mediated targeting liposomes. In: Liposome-Based Drug Deliv. Syst. Lu WL, Qi XR ( Eds). Springer, Heidelberg, Germany, 167–178 (2021).
   Google Scholar
• Yang Y, Zhao Z, Xie C, Zhao Y. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer. Chem. Phys. Lipids 228, 104882 (2020).
   PubMed Web of Science ®Google Scholar
• Münter R, Kristensen K, Pedersbæk D, Andresen TL, Simonsen JB, Larsen JB. Quantitative methods for investigating dissociation of fluorescently labeled lipids from drug delivery liposomes. In: Nanotechnology Characterization Tools for Tissue Engineering and Medical Therapy. Kumar C (Ed.).Springer, Heidelberg, Germany, 333–359 (2019).
   Google Scholar
• Shuai Q, Zhao G, Zhang X, Yu B, Lee RJ, Su W-K. Selection of fluorescent dye for tracking biodistribution of paclitaxel in live imaging. Colloid. Surf. B Biointerfaces 181, 872–878 (2019).
   PubMed Web of Science ®Google Scholar
• Chen Y, Li L, Chen W, Chen H, Yin J. Near-infrared small molecular fluorescent dyes for photothermal therapy. Chin. Chem. Lett. 30(7), 1353–1360 (2019).
   Web of Science ®Google Scholar
• Bandi VG, Luciano MP, Saccomano M et al. Targeted multicolor in vivo imaging over 1,000 nm enabled by nonamethine cyanines. Nat. Methods 19(3), 353–358 (2022).
   PubMed Web of Science ®Google Scholar
• Kala SG, Chinni S. Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies. Drug Deliv. Transl. Res. 12(11), 2856–2864 (2022).
   PubMed Web of Science ®Google Scholar
• Lozano N, Al-Ahmady ZS, Beziere NS, Ntziachristos V, Kostarelos K. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent. Int. J. Pharm. 482(1-2), 2–10 (2015).
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhou Y, Chen J, Huang N, Wang Z, Cheng Y. Gene therapy for drug-resistant glioblastoma via lipid-polymer hybrid nanoparticles combined with focused ultrasound. Int. J. Nanomed. 16, 185 (2021).
   PubMed Web of Science ®Google Scholar
• Sun S, Wang P, Sun S, Liang X. Applications of micro/nanotechnology in ultrasound-based drug delivery and therapy for tumor. Curr. Med. Chem. 28(3), 525–547 (2021).
   PubMed Web of Science ®Google Scholar
• Wei P, Cornel EJ, Du J. Ultrasound-responsive polymer-based drug delivery systems. Drug Deliv. Transl. Res. 11(4), 1323–1339 (2021).
   PubMed Web of Science ®Google Scholar
• Mo L, Song JG, Lee H et al. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure. Nanomed. Nanotechnol. Biol. Med. 14(2), 557–567 (2018).
   PubMed Web of Science ®Google Scholar
• Bicak B, Gunduz SK, Ozel AE. Advancements in cancer therapeutics: targeted drug delivery in cancer treatment. In: Handbook of Research on Advancements in Cancer Therapeutics. IGI Global, PA, USA, 382– 412 (2021).
   Google Scholar
• Thomas E, Menon JU, Owen J et al. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. Theranostics 9(19), 5595 (2019).
   PubMed Web of Science ®Google Scholar
• Paris JL, Mannaris C, Cabañas MV et al. Ultrasound-mediated cavitation-enhanced extravasation of mesoporous silica nanoparticles for controlled-release drug delivery. Chem. Eng. J. 340, 2–8 (2018).
   Web of Science ®Google Scholar
• Jung O, Thomas A, Burks SR et al. Neuroinflammation associated with ultrasound-mediated permeabilization of the blood–brain barrier. Trends Neurosci. 45(6), 459–470 (2022).
   PubMed Web of Science ®Google Scholar
• Ahmed R, Ye J, Gerber SA, Linehan DC, Doyley MM. Preclinical imaging using single track location shear wave elastography: monitoring the progression of murine pancreatic tumor liver metastasis in vivo. IEEE Trans. Med. Imaging 39(7), 2426–2439 (2020).
   PubMed Web of Science ®Google Scholar
• Arsiwala TA, Sprowls SA, Blethen KE et al. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery. Neoplasia 23(7), 676–691 (2021).
   PubMed Web of Science ®Google Scholar
• Xia H, Yang D, He W et al. Ultrasound-mediated microbubbles cavitation enhanced chemotherapy of advanced prostate cancer by increasing the permeability of blood–prostate barrier. Transl. Oncol. 14(10), 101177 (2021).
   PubMed Web of Science ®Google Scholar
• De Matos MB, Deckers R, van Elburg B et al. Ultrasound-sensitive liposomes for triggered macromolecular drug delivery: formulation and in vitro characterization. Front. Pharmacol. 10, 1463 (2019).
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang T, Sun S, Ren W, Wu A, Xu H. Ultrasound-mediated cavitation enhances EGFR-targeting PLGA-PEG nano-micelle delivery for triple-negative breast cancer treatment. Cancers 13(14), 3383 (2021).
   PubMed Web of Science ®Google Scholar
• Novell A, Al Sabbagh C, Escoffre J-M et al. Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes. Int. J. Hyperthermia 31(4), 349–358 (2015).
   PubMed Web of Science ®Google Scholar
• Lin X, Song J, Chen X, Yang H. Ultrasound-activated sensitizers and applications. Angew. Chem. Int. Ed. 59(34), 14212–14233 (2020).
   PubMed Web of Science ®Google Scholar
• Grigoletto A, Martinez G, Gabbia D et al. Folic acid-targeted paclitaxel–polymer conjugates exert selective cytotoxicity and modulate invasiveness of colon cancer cells. Pharmaceutics 13(7), 929 (2021).
   PubMed Web of Science ®Google Scholar
• Sohail MF, Javed I, Hussain SZ et al. Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel. J. Mater. Chem. B 4(37), 6240–6248 (2016).
   PubMed Web of Science ®Google Scholar
• Kalaichelvi R, Jayachandren E. UV spectrophotometric estimation of sorafenib in pure and tablet dosage form. J. Pharm. Res. 4(10), 3705–3706 (2011).
   Google Scholar
• Fatima S, Mansha A, Asim S, Shahzad A. Absorption spectra of coumarin and its derivatives. Chem. Pap. 76, 627–638 (2021).
   Web of Science ®Google Scholar
• Mannaris C, Bau L, Grundy M et al. Microbubbles, nanodroplets and gas-stabilizing solid particles for ultrasound-mediated extravasation of unencapsulated drugs: an exposure parameter optimization study. Ultrasound Med. Biol. 45(4), 954–967 (2019).
   PubMed Web of Science ®Google Scholar
• Luo Q, Yang J, Xu H et al. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study. Drug Deliv. 29(1), 837–855 (2022).
   PubMed Web of Science ®Google Scholar
• Rehman M, Raza A, Khan JA, Zia MA. Laser responsive cisplatin-gold nano-assembly synergizes the effect of cisplatin with compliance. J. Pharm. Sci. 110(4), 1749–1760 (2021).
   PubMed Web of Science ®Google Scholar
• Hassan A, Ikram A, Raza A et al. Therapeutic potential of novel mastoparan-chitosan nanoconstructs against clinical MDR Acinetobacter baumannii: in silico, in vitro and in vivo studies. Int. J. Nanomed. 16, 3755 (2021).
   PubMed Web of Science ®Google Scholar
• Kanwal U, Bukhari NI, Rana NF et al. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs. Int. J. Nanomed. 14, 1 (2019).
   PubMed Web of Science ®Google Scholar
• Liao A-H, Lin K-H, Chuang H-C et al. Low-frequency dual-frequency ultrasound-mediated microbubble cavitation for transdermal minoxidil delivery and hair growth enhancement. Sci. Rep. 10(1), 1–12 (2020).
   PubMed Web of Science ®Google Scholar
• Ye D, Chen H. Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN). MethodsX 8, 101266 (2021).
   PubMed Web of Science ®Google Scholar
• Ahiwale RJ, Chellampillai B, Pawar AP. Investigation of novel sorafenib tosylate loaded biomaterial based nano-cochleates dispersion system for treatment of hepatocellular carcinoma. J. Dispers. Sci. Technol. 43(10), 1568–1586 (2021).
   Web of Science ®Google Scholar
• Patil O, Ingalagondi PK, Mathapati GB, Hanagodimath SM. Analysis of fluorescence quenching of coumarin derivative dye using Stern–Volmer plots. In: AIP Conference Proceedings. Appleton BR (Ed.). AIP Publishing LLC, 180007, NY, USA (2019).
   Google Scholar
• Umbarkar M, Thakare S, Surushe T, Giri A, Chopade V. Formulation and evaluation of liposome by thin film hydration method. J. Drug Deliv. Ther. 11(1), 72–76 (2021).
   Google Scholar
• Abshire C, Murad HY, Arora JS et al. Focused ultrasound-triggered release of tyrosine kinase inhibitor from thermosensitive liposomes for treatment of renal cell carcinoma. J. Pharm. Sci. 106(5), 1355–1362 (2017).
   PubMed Web of Science ®Google Scholar
• Moyano DB, Paraiso DA, González-Lezcano RA. Possible effects on health of ultrasound exposure, risk factors in the work environment and occupational safety review. In: Healthcare. Romero-Morales C, De-la-Cruz-Torres B, Valera-Garrido F (Eds). MDPI, Basel, Switzerland, 423 (2022).
   Google Scholar
• O’Leary B, Vaezy S. Marketing clearance of diagnostic ultrasound systems and transducers. Guidance for Industry and Food and Drug Administration Staff (2019). https://www.fda.gov/media/71100/download
   Google Scholar
• Fowlkes JB, Holland CK. Mechanical bioeffects from diagnostic ultrasound: AIUM consensus statement - introduction. J. Ultrasound Med. 19, 69–72 (2000).
   PubMed Web of Science ®Google Scholar
• Nelson TR, Fowlkes JB, Abramowicz JS, Church CC. Ultrasound biosafety considerations for the practicing sonographer and sonologist. J. Ultrasound Med. 28(2), 139–150 (2009).
   PubMed Web of Science ®Google Scholar
• Şen T, Tüfekçioğlu O, Koza Y. Mechanical index. Anatol. J. Cardiol. 15(4), 334 (2015).
   PubMed Web of Science ®Google Scholar
• Karthikesh MS, Yang X. The effect of ultrasound cavitation on endothelial cells. Exp. Biol. Med. 246(7), 758–770 (2021).
   Web of Science ®Google Scholar
• Omar MM, Hasan OA, Zaki RM, Eleraky NE. Externally triggered novel rapid-release sonosensitive folate-modified liposomes for gemcitabine: development and characteristics. Int. J. Nanomed. 16, 683 (2021).
   PubMed Web of Science ®Google Scholar
• Upputuri RTP, Mandal AKA. Mathematical modeling and release kinetics of green tea polyphenols released from casein nanoparticles. Iran. J. Pharm. Res. IJPR 18(3), 1137 (2019).
   PubMed Web of Science ®Google Scholar
• Khezri K, Saeedi M, Morteza-Semnani K, Akbari J, Hedayatizadeh-Omran A. A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier. Artif. Cells Nanomed. Biotechnol. 49(1), 38–47 (2021).
   PubMed Web of Science ®Google Scholar
• Yildirim H, Aydemir O, Balbaba M, Özercan İH, İlhan N. Comparison of the effect of topical bevacizumab and sorafenib in experimental corneal neovascularization. Cutan. Ocul. Toxicol. 39(3), 223–228 (2020).
   PubMed Web of Science ®Google Scholar
• Haghiralsadat F, Amoabediny G, Helder MN et al. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artif. Cells Nanomed. Biotechnol. 46(1), 169–177 (2018).
   PubMed Web of Science ®Google Scholar
• Soe ZC, Thapa RK, Ou W et al. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloid. Surf. B Biointerfaces 170, 718–728 (2018).
   PubMed Web of Science ®Google Scholar
• Patil Y, Amitay Y, Ohana P, Shmeeda H, Gabizon A. Targeting of PEGylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: intracellular activation and enhanced cytotoxicity. J. Control. Rel. 225, 87–95 (2016).
   PubMed Web of Science ®Google Scholar
• Soga K, Tokuzen K, Tsuji K, Yamano T, Hyodo H, Kishimoto H. NIR bioimaging: development of liposome-encapsulated, rare-earth-doped Y2O3 nanoparticles as fluorescent probes. Eur. JIC 2010(18), 2673–2677 (2010).
   Google Scholar
• Kodama T, Tomita N, Yagishita Y et al. Volumetric and angiogenic evaluation of antitumor effects with acoustic liposome and high-frequency ultrasound. Cancer Res. 71(22), 6957–6964 (2011).
   PubMed Web of Science ®Google Scholar
• Strumberg D. Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment. Drugs Today Barc. 41(12), 773–784 (2005).
   PubMed Web of Science ®Google Scholar
• Kane RC, Farrell AT, Saber H et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin. Cancer Res. 12(24), 7271–7278 (2006).
   PubMed Web of Science ®Google Scholar
• Sheng X, Huang T, Qin J et al. Preparation, pharmacokinetics, tissue distribution and antitumor effect of sorafenib-incorporating nanoparticles in vivo. Oncol. Lett. 14(5), 6163–6169 (2017).
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie H, Ying K et al. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies. Biomaterials 270, 120705 (2021).
   PubMed Web of Science ®Google Scholar